HAP Trading’s Anika Therapeutics ANIK Stock Holding History

HAP Trading’s Portfolio ANIK Stock Details ANIK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-14,574	Closed	-$615K	–	1119
2018 Q3	$615K	Buy	+14,574	New	+$576K	0.04%	276

Other funds holding ANIK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HAP Trading's ANIK Position: Q4 2018 in Review

HAP Trading sold out of Anika Therapeutics (ANIK) in Q4 2018, closing a stake of 14,574 shares — an estimated $615K sold.

HAP Trading first reported a position in ANIK in Q3 2018 and held it in 1 quarter. The position peaked at $615K in Q3 2018. 162 funds tracked by Wall St. Rank hold ANIK as of Q4 2018.

HAP Trading reported no remaining Anika Therapeutics position as of Q4 2018 after selling out during the quarter.
HAP Trading sold 14,574 Anika Therapeutics shares in Q4 2018, an estimated $615K.
HAP Trading first reported a position in Anika Therapeutics in Q3 2018 and held it in 1 quarter.
HAP Trading's Anika Therapeutics position peaked at $615K in Q3 2018.
162 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2018.

Based on HAP Trading's 13F filing for Q4 2018, filed 12 Feb 2019.